Congress investigates lifting some cannabis restrictions

CNN
1d
2m read
Summary

The FDA's ongoing review of the wildly popular cannabis compound cannabidiol (CBD) remains ongoing, said Dr. At the same time, cannabis remains illegal federally, creating a rash of conflicts and complications in areas such as research, banking, taxes and commerce. Although federal cannabis legalization may not be imminent, Congress is taking early steps to better understand how to research and regulate the complex plant. During Wednesday's hearing, legislators took a crack at cannabis' chicken-and-egg problem: Cannabis remains a Schedule I substance -- the most restrictive class and identified as having no medical use -- because of a lack of comprehensive research. The Health subcommittee of the US House Committee on Energy and Commerce on Wednesday joined the shortlist of subcommittees that have delved into cannabis.

Article Preview

Cannabis continues to make history on Capitol Hill — albeit incrementally. Although federal cannabis legalization may not be imminent, Congress is taking early steps to better understand how to research and regulate the complex plant. The Health subcommittee of the US House Committee on Energy and Commerce on Wednesday joined the shortlist of subcommittees that have delved into cannabis. No votes were cast nor policy decisions made, but the 3 1/2-hour hearing — the first-ever cannabis hearing for the Energy and Commerce committee — provided windows into legislators' temperatures on cannabis legalization and the actions undertaken to-date by a trio of...

Read the full article @ CNN